Search
Becampanel
go.drugbank.com/drugs/DB21365ExperimentalBecampanel is a small molecule drug. Becampanel has a monoisotopic molecular weight of 330.04 Da.
Lotilibcin
go.drugbank.com/drugs/DB21386ExperimentalLotilibcin is a small molecule drug. Lotilibcin has a monoisotopic molecular weight of 1561.81 Da.
Remeglurant
go.drugbank.com/drugs/DB21403ExperimentalRemeglurant is a small molecule drug. Remeglurant has a monoisotopic molecular weight of 370.04 Da.
Sornidipine
go.drugbank.com/drugs/DB21432ExperimentalSornidipine is a small molecule drug. The usage of the INN stem '-dipine' in the name indicates that Sornidipine is a calcium channel blocker, nifedipine derivative. … Sornidipine has a monoisotopic molecular weight of 460.15 Da.
Lm-LLO-TT
go.drugbank.com/drugs/DB33966ExperimentalLm-LLO-TT is a biologic drug. Lm-LLO-TT is under investigation in clinical trial NCT07828236 (PHASE 1 TRIAL OF Lm-LLO-TT AND GEMCITABINE IN UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA).
SRN-101
go.drugbank.com/drugs/DB33962ExperimentalSRN-101 is a biologic drug. … SRN-101 is under investigation in clinical trial NCT07826949 (A Phase 1 Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.).
SGX-001
go.drugbank.com/drugs/DB33968ExperimentalSGX-001 is a biologic drug. SGX-001 is under investigation in clinical trial NCT07826767 (Open-label Gene Therapy Study in p47-CGD).
BI 4060107
go.drugbank.com/drugs/DB33963ExperimentalBI 4060107 is a small molecule drug. … BI 4060107 is under investigation in clinical trial NCT07827144 (A Study to Test How Well Different Doses of BI 4060107 Are Tolerated by People With Advanced Cancer (Solid Tumours)).
161Tb-PSMA-1
go.drugbank.com/drugs/DB33964Experimental161Tb-PSMA-1 is a small molecule drug. 161Tb-PSMA-1 is under investigation in clinical trial NCT07828249 (Phase I Study Evaluating 161Tb-PSMA Therapy in Adult Patients With Metastatic Clear Cell Renal
JUR-003
go.drugbank.com/drugs/DB33972ExperimentalJUR-003 is a small molecule drug. JUR-003 is under investigation in clinical trial NCT07824349 (JUR-003 in Adult Patients With Metastatic Prostate Cancer).